Sarepta Therapeutics, Inc. (SRPT)
15.90
+0.35
(+2.25%)
USD |
NASDAQ |
Jun 09, 16:00
15.83
-0.07
(-0.44%)
After-Hours: 18:17
Sarepta Therapeutics SG&A Expense (Quarterly) : 108.95M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 41.74M |
| Moderna, Inc. | 173.00M |
| Denali Therapeutics, Inc. | 33.51M |
| Twist Bioscience Corp. | 76.08M |
| Revolution Medicines, Inc. | 101.25M |